{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:03:52Z","timestamp":1767845032027,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Vaccines against<jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>type B (Hib),<jats:italic toggle=\"yes\">Neisseria meningitidis<\/jats:italic>and<jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>have been serially introduced into the New Zealand national immunization schedule since the 1990s. This study aimed to describe long-term trends in the rates of these invasive bacterial infections in children from New Zealand and compare these to recent UK data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This population-based observational study used 2 national datasets that collect data about hospital discharges (National Minimum Dataset) and notifiable diseases (Epurv). Annual age-specific and age-standardized hospital admission rates and notification rates were analyzed for all children &lt;15 years of age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Hospital admissions for Hib reduced by 79% during the 2 years after the introduction of the Hib vaccine (5.94\u20131.24\/100,000). Meningococcal disease notifications fell by 75% over 8 years after the introduction of MeNZB vaccine (26.15\u20132.48\/100,000) and have continued to decline. Meningococcal disease rates were lower than in the United Kingdom despite the absence of an ongoing meningococcal vaccination program in New Zealand (8.16 compared with 10.37\/100,000 for 2007\u20132011). There rates of notifications and hospital admissions for pneumococcal disease were discordant, but both reduced substantially after the introduction of pneumococcal conjugate vaccines. Maori children had the highest rates of disease and the greatest reduction in rates after the introduction of both meningococcal and pneumococcal vaccines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Vaccines have had a substantial impact on the rates of invasive bacterial disease in children from New Zealand because of Hib, pneumococcus and meningococcus. Reductions in rates of disease have been greatest in Maori children, improving longstanding disparities in disease burden.<\/jats:p><\/jats:sec>","DOI":"10.1097\/inf.0000000000002071","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T22:10:07Z","timestamp":1524262207000},"page":"1041-1047","source":"Crossref","is-referenced-by-count":11,"title":["Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children"],"prefix":"10.1097","volume":"37","author":[{"given":"Tony","family":"Walls","sequence":"first","affiliation":[{"name":"Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Williman","sequence":"additional","affiliation":[{"name":"Department of Population Health, University of Otago, Christchurch, New Zealand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Brunton","sequence":"additional","affiliation":[{"name":"Department of Population Health, University of Otago, Christchurch, New Zealand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1754.2010.01969.x","article-title":"Reducing inequalities with vaccines: New Zealand\u2019s MeNZB vaccine initiative to control an epidemic.","volume":"48","author":"Lennon","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(03)13693-8","article-title":"Bacterial meningitis in children.","volume":"361","author":"S\u00e1ez-Llorens","year":"2003","journal-title":"Lancet"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archpedi.1994.02170010049010","article-title":"Epiglottitis in children, 1979 through 1992. Effects of Haemophilus influenzae type b immunization.","volume":"148","author":"Gorelick","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00005537-200403000-00031","article-title":"Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends.","volume":"114","author":"Shah","year":"2004","journal-title":"Laryngoscope"},{"key":"R6-20230912","first-page":"86","article-title":"The further and future evolution of the New Zealand Immunisation Schedule.","volume":"125","author":"Reid","year":"2012","journal-title":"N Z Med J"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/603552","article-title":"Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.","volume":"49","author":"Lennon","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-20230912","first-page":"U122","article-title":"The beneficial impact of Hib vaccine on disease rates in New Zealand children.","volume":"115","author":"Wilson","year":"2002","journal-title":"N Z Med J"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1016\/j.vaccine.2008.08.062","article-title":"MeNZB vaccine and epidemic control: when do you stop vaccinating?","volume":"26","author":"Loring","year":"2008","journal-title":"Vaccine"},{"key":"R11-20230912","first-page":"208","article-title":"The changing face of epiglottitis in Canterbury 1970-1996.","volume":"111","author":"Sivertsen","year":"1998","journal-title":"N Z Med J"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","article-title":"Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.","volume":"14","author":"Martin","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2011.06.120","article-title":"Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.","volume":"29","author":"Arnold","year":"2011","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R15-20230912","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease.","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(11)61780-7","article-title":"Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study.","volume":"379","author":"Baker","year":"2012","journal-title":"Lancet"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"316","DOI":"10.33321\/cdi.2008.32.32","article-title":"Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005.","volume":"32","author":"Wang","year":"2008","journal-title":"Commun Dis Intell Q Rep"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience.","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00006454-199307000-00009","article-title":"Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.","volume":"12","author":"Mohle-Boetani","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1046\/j.1440-1754.2001.00722.x","article-title":"A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000.","volume":"37","author":"Baker","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"R26-20230912","first-page":"437","article-title":"Meningococcal disease epidemiology and control in New Zealand.","volume":"108","author":"Wilson","year":"1995","journal-title":"N Z Med J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201810000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T20:51:50Z","timestamp":1751575910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201810000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002071","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}